The news is by your side.


‘We have a healthy spacecraft’: NASA succeeds in historic flyby of faraway world

TAMPA: NASA rang in the New Year on Tuesday with a historic flyby of the farthest, and quite possibly the oldest, cosmic body ever explored by humankind -- a tiny, distant world called Ultima Thule -- in the hopes of learning more about how planets took shape. A series of anxiously awaited "phone home" signals arrived after 10:30 am (1530 GMT), indicating that the spacecraft had made it, intact, through the risky, high-speed encounter. "We have a healthy spacecraft," said mission operations manager Alice Bowman, as…

Merck drug Keytruda succeeds in late-stage esophageal cancer trial

Merck & Co’s blockbuster drug Keytruda met the main goal of a late-stage trial testing the treatment in patients with cancers of the digestive tract, the US drugmaker said on Wednesday. Keytruda, among a class of medicines called PD-1 inhibitors, is Merck’s top selling drug and has already been approved to treat several forms of cancer including skin and lung cancer. PD-1 or PD-L1 inhibitors work by blocking a mechanism of tumors that allows them to evade detection by cancer-fighting cells. Keytruda, when…

Roche’s emicizumab haemophilia drug succeeds in trial

SHANGHAI: Roche Holding AG's emicizumab drug for treating haemophilia A showed it worked in a phase III study, the Swiss drugmaker said on Thursday. Roche is hoping to win a slice of the $11 billion-a-year haemophilia drug market with the drug, also known as ACE910, which represents a threat to more traditional treatments from Novo Nordisk and Shire. Roche's drug is being closely watched because it could change the way the disease is treated. The study showed a statistically significant reduction in the number of…